Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe

OBJECTIVE: To assess the current medical practice in Europe regarding prenatal dexamethasone (Pdex) treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. DESIGN AND METHODS: A questionnaire was designed and distributed, including 17 questions collecting quantitative and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowotny, Hanna, Neumann, Uta, Tardy-Guidollet, Véronique, Ahmed, S Faisal, Baronio, Federico, Battelino, Tadej, Bertherat, Jérôme, Blankenstein, Oliver, Bonomi, Marco, Bouvattier, Claire, Brac de la Perrière, Aude, Brucker, Sara, Cappa, Marco, Chanson, Philippe, Claahsen-van der Grinten, Hedi L, Colao, Annamaria, Cools, Martine, Davies, Justin H, Dörr, Helmut-Günther, Fenske, Wiebke K, Ghigo, Ezio, Giordano, Roberta, Gravholt, Claus H, Huebner, Angela, Husebye, Eystein Sverre, Igbokwe, Rebecca, Juul, Anders, Kiefer, Florian W, Léger, Juliane, Menassa, Rita, Meyer, Gesine, Neocleous, Vassos, Phylactou, Leonidas A, Rohayem, Julia, Russo, Gianni, Scaroni, Carla, Touraine, Philippe, Unger, Nicole, Vojtková, Jarmila, Yeste, Diego, Lajic, Svetlana, Reisch, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010809/
https://www.ncbi.nlm.nih.gov/pubmed/35235536
http://dx.doi.org/10.1530/EJE-21-0554

Ejemplares similares

Ejemplares similares